 OncLive | Breast Oncologists Incorporate New Treatments, Grapple With Ongoing ... OncLive Everolimus, recently approved in estrogen receptor [ER]-positive metastatic breast cancer, is being tested in combination with trastuzumab in HER2-positive disease in the first-line and later-line settings. However, the toxicity profile of everolimus ... |
